micro-community-banner
 
  • Saved

The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis

The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis

Source : https://nn.neurology.org/content/8/5/e1043.abstract

Objective To evaluate the aryl hydrocarbon receptor (AHR)-dependent transforming growth factor alpha (TGF-α)/vascular endothelial growth factor B (VEGF-B) ratio, which regulates the effects of metabolic, dietary, and microbial factors on...

  • Saved

Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations

Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations

Source : https://www.mdpi.com/2076-393X/9/7/773

Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine response dynamics. A systematic review on...

  • Saved

  • Saved

  • Saved

Preferences for Multiple Sclerosis Treatments in the US | PPA

Preferences for Multiple Sclerosis Treatments in the US | PPA

Source : https://www.dovepress.com/patient-and-neurologist-preferences-in-the-united-states-for-relapsing-peer-reviewed-fulltext-article-PPA

Multiple sclerosis (MS), a chronic inflammatory disease, involves damage to the central nervous system and impairments in neurologic function. More than 2 million people worldwide have MS, with nearly 1...